Tapering of SSRI treatment to mitigate withdrawal symptoms - Authors' reply
Lancet Psychiatry
.
2019 Jul;6(7):562-563.
doi: 10.1016/S2215-0366(19)30219-6.
Authors
Mark Abie Horowitz
1
,
David Taylor
2
Affiliations
1
Prince of Wales Hospital, Sydney, NSW 2031, Australia. Electronic address: mark_horo@hotmail.com.
2
Institute of Pharmaceutical Science, King's College London, London, UK.
PMID:
31230678
DOI:
10.1016/S2215-0366(19)30219-6
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Substance Withdrawal Syndrome*